Promega corporation:1107424 [16-055910]
Ended Awarded
- Contract number
- HHSN26100001
- Awardee
-
Promega Corporation UEI MWM4N9L4S5X4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,384
Award facts
- Contract value 100% obligated
- $10,384.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Madison, WI 53711, USA
Award details come from SAM.gov/FPDS.
About this award
Promega Corporation received a $10,384 firm fixed price call under a Blanket Purchase Agreement from the National Cancer Institute on August 5, 2016, with an ultimate completion date of August 19, 2016. This contract award, which carries no small business set-aside designation, represents a task order placed against Promega's existing $10 million BPA with the National Institutes of Health's Office of Logistics and Acquisition Operations. The BPA vehicle covers biological materials, chemicals, medical and scientific equipment, and maintenance services, enabling the National Cancer Institute and other NIH component agencies to efficiently procure specialized research products and consumables.
As a leading global life sciences company headquartered in Madison, Wisconsin, Promega supplies advanced scientific technologies and laboratory reagents to federal agencies supporting critical research missions. The company's product offerings include DNA analysis systems, molecular diagnostic tools, automated nucleic acid extraction systems, and specialized research instruments that align with the National Cancer Institute's biomedical research requirements. Promega's status as a large business contractor, combined with its extensive experience fulfilling federal research and forensic needs across multiple agencies including the Centers for Disease Control and Prevention, Food and Drug Administration, and Federal Bureau of Investigation, positions the company to meet complex government procurement demands.
Quick answers
Who was awarded contract HHSN26100001?
HHSN26100001 was awarded to Promega Corporation by National Cancer Institute (National Institutes of Health) on August 5, 2016.
How much is contract HHSN26100001 worth?
The government has obligated $10,384 on HHSN26100001.
Is contract HHSN26100001 an order under another contract?
Yes. HHSN26100001 is a BPA call under HHSN263201500038B, a blanket purchase agreement.
Was contract HHSN26100001 competed?
The extent of competition for HHSN26100001 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award